SureSwab® - Bacterial Vaginosis and Vaginitis Test
Why test for everything, when you can simply test for the right thing?
Quest Diagnostics offers organism-specific molecular tests available individually or in panels. Because of the close association between STIs and bacterial vaginosis and Candida infection, the SureSwab® Vaginosis/Vaginitis Plus panel includes tests for C. trachomatis, N. gonorrhoeae, and T. vaginalis as well as tests for bacterial vaginosis and Candida spp.
SureSwab®… a difference in BVV testing
- An accurate diagnosis of Bacterial Vaginosis and Vaginitis (BVV) depends on more than identifying the presence of organisms. Vaginosis occurs when the balance of the bacterial flora in the vaginal ecosystem is disrupted.[[1 - 5]
- SureSwab is a molecular, quantitative test for vaginosis with results that support a more definitive diagnosis.
- SureSwab provides a clear indication as to whether or not an imbalance exists versus conventional qualitative approaches that test for a broad array of organisms.
Targeted Testing Is the Most Clinically Appropriate Choice for Women with:
- Symptoms of Vaginitis
- History of high-risk sexual behavior or a previous STI
- History of pregnancy complications (e.g. ectopic pregnancy, premature rupture of the membranes preterm labor and delivery)
- Cervictis, pelvic inflammatory disease, urethritis
- Chronic pelvic pain, difficult urination, painful intercourse
- Risk of post-operative gynecologic infection
Online Resources for Healthcare Professionals
- Visit our Test Selection and Interpretation Guide for information relating to test selection, utilization and interpretation.
- Obtain test ordering codes and specimen requirements from our online Test Menu
- Simplify test ordering and reporting with our connectivity solutions
Contact a Quest Diagnostics Sales Representative, learn more about our testing services, and become a client
- Contact a physician sales representative
- Contact a hospital sales representative or learn about our complete hospital offerings
- Egan M and Lipsky M. Diagnosis of Vaginitis. Am Fam Physician 200;621095-1104
- Fredricks DN Fiedler TL, Marrazzo JM Molecular identification of bacterial associated with bacterial vaginosis, N Engl J Med. 2005;353:1899-1911
- Menard JP,Fenollar F. Henry M. Et al. Molecular quantification of Gardnerella vaginalis and Atopobium vaginae loads to predict bacterial vaginosis. Clin Infect Dis.2008;47:33-43
- Ferris M. et al. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infectious Diseases 2004;4-5
- Zozaya-Hinchliffe M. Martin DH, Ferris MJ. Prevalence and abundance of uncultivated Megasphera-like bacteria in the human vaginal environment. Appl Environ Microbiol. 2008;74;1656-1659
- Centers for Disease Control and Prevention, Workowski KA. Berman SM. Sexually transmitted diseases treatment guidelines 2006. MMWR Recomm Rep. 2006;55(RR-11);1-94 Erratum in:MMWR Recomm Rep. 2006;56-997.